Stockscreener 앱 받기
3.56
8.87%
0.29
전일 마감가:
$3.27
열려 있는:
$3.27
하루 거래량:
783.00K
Relative Volume:
1.01
시가총액:
$198.12M
수익:
$69.23M
순이익/손실:
$-33.10M
주가수익비율:
-3.0169
EPS:
-1.18
순현금흐름:
$-39.26M
1주 성능:
+4.40%
1개월 성능:
+126.75%
6개월 성능:
+97.78%
1년 성능:
+1.14%
1일 변동 폭
$3.2201
$3.65
1주일 범위
$2.88
$3.65
52주 변동 폭
$0.52
$5.0699
Neuronetics Inc Stock (STIM) Company Profile
명칭
Neuronetics Inc
전화
877-600-7555
주소
3222 PHOENIXVILLE PIKE, MALVERN, PA
STIM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
3.56 | 198.12M | 69.23M | -33.10M | -39.26M | -1.18 |
|
TMO
Thermo Fisher Scientific Inc
|
572.71 | 219.06B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
210.01 | 151.02B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
147.64 | 42.12B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
209.96 | 38.11B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
460.56 | 37.71B | 3.84B | 866.24M | 792.60M | 10.37 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-10-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2018-07-24 | 개시 | Canaccord Genuity | Buy |
모두보기
Neuronetics Inc 주식(STIM)의 최신 뉴스
Neuronetics announces public stock offering By Investing.com - Investing.com South Africa
Neuronetics announces public stock offering - Investing.com India
Neuronetics Announces Launch of Underwritten Public Offering of Common Stock - The Manila Times
Major Stock Offering Alert: Neuronetics Takes Bold Step to Raise Capital Through Public Markets - StockTitan
Are Smart Investors Making the Right Decision? Neuronetics Inc (STIM) - SETE News
Medical Transcranial Magnetic Stimulator Market Generated - openPR
Neuronetics Inc (STIM)’s stock chart: A technical perspective - US Post News
Market Momentum Report: Neuronetics Inc (STIM)’s Positive Close at 3.45 - The Dwinnex
Neuronetics Inc (STIM) rating downgrades by William Blair - Knox Daily
Unlocking the Healthcare Boom: Why Neuronetics is a Game-Changer for Investors - Jomfruland.net
Why Neuronetics Inc (STIM) Is Skyrocketing So Far In 2025 - Insider Monkey
Short Interest in Neuronetics, Inc. (NASDAQ:STIM) Drops By 35.8% - MarketBeat
NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression - The Manila Times
NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression -January 29, 2025 at 08:32 am EST - Marketscreener.com
NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression -January 29, 2025 at 08:31 am EST - Marketscreener.com
Neuronetics, Inc. Unveils Two Significant Publications on TMS Therapy for Depression - Marketscreener.com
Neuronetics (NASDAQ:STIM) shareholders are up 34% this past week, but still in the red over the last five years - Yahoo Finance
Breakthrough Depression Treatment Achieves Universal Success Rate, Research Confirms - StockTitan
Neuronetics Reports 2024 Revenue Growth, Reveals Optimistic 2025 Guidance - MSN
Neuronetics (NASDAQ: STIM) Files 8-K with Preliminary Financial Information - Defense World
Neuronetics, Inc. Announces Unaudited Revenue Results for Fourth Quarter and Full Year 2024 - Marketscreener.com
Neuronetics, Inc. (NASDAQ:STIM) Sees Significant Drop in Short Interest - MarketBeat
Neuronetics forecasts revenue growth and cost savings post-acquisition - Investing.com India
Neuronetics Projects Growth Following Greenbrook Acquisition - TipRanks
Neuronetics Provides Business Update and Issues 2025 Guidance - The Manila Times
Neuronetics Projects Strong 2025 Growth, Expands NeuroStar Depression Treatment to Teens - StockTitan
Neuronetics, Inc.'s (NASDAQ:STIM) Shares Leap 43% Yet They're Still Not Telling The Full Story - Simply Wall St
Transcranial Magnetic Stimulator Market Growth in Future Scope - openPR
Transcranial Magnetic Stimulator Market Report, Size, Trends, - openPR
Critical Survey: Neuronetics (NASDAQ:STIM) vs. Tenon Medical (NASDAQ:TNON) - Defense World
Neuronetics Awards Stock Units to New Employee Bill Leonard - MSN
Neuronetics (NASDAQ:STIM) Is Making Moderate Use Of Debt - Simply Wall St
HighTower Advisors LLC Increases Stock Holdings in Neuronetics, Inc. (NASDAQ:STIM) - Defense World
Neuronetics (STU:NRC) Future 3-5Y EPS without NRI Growth Ra - GuruFocus.com
Neuronetics Revamps TrakStar System, Streamlining Patient Data Management - MSN
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Neuronetics Grants Strategic 50,000 PRSU Inducement Award to Key New Employee - StockTitan
Neuronetics' SWOT analysis: merger impact on neurohealth stock By Investing.com - Investing.com Australia
Neuronetics Unveils Strategic Performance-Based Stock Awards Targeting Cash Flow Breakeven by 2025 - StockTitan
Neuronetics' SWOT analysis: merger impact on neurohealth stock - Investing.com
Neuronetics, Greenbrook TMS close transaction - Medical Buyer
Neuronetics Expands with Greenbrook TMS Acquisition - TipRanks
Madryn Provides Update on Holdings of Greenbrook TMS Inc. - The Manila Times
Neuronetics and Greenbrook TMS Announce Closing of Transaction - The Manila Times
Reviewing Stryker (NYSE:SYK) & Neuronetics (NASDAQ:STIM) - Defense World
Neuronetics' SWOT analysis: merger, market challenges shape TMS stock outlook - Investing.com Nigeria
Neuronetics (STU:NRC) 3-Year EPS without NRI Growth Rate : 9.40% (As of Sep. 2024) - GuruFocus.com
Neuronetics Inc (STIM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.51%
자본화:
|
볼륨(24시간):